Streetbeat News

Products Services

VKTX

The article discusses key considerations for investors interested in Viking Therapeutics (VKTX), highlighting potential growth opportunities and risks associated with the company.

Portfolio Pulse from

November 18, 2024 | 10:00 am

MLSPF

Melrose Industries PLC's latest trading update indicates that its positive forward guidance has outweighed concerns about ongoing supply-chain issues, leading to a surge in its stock price.

Portfolio Pulse from

November 18, 2024 | 9:45 am

SCNLF

Panmure Liberum has reiterated its 'buy' recommendation for Scancell Holdings PLC shares following a positive update from its phase II SCOPE clinical trial for the cancer vaccine SCIB1.

Portfolio Pulse from

November 18, 2024 | 9:45 am

BLBD

Blue Bird has shown strong growth in revenue and profits, driven by strategic pricing and a favorable product mix. The company is investing in production capacity and focusing on alternative fuel buses, benefiting from regulatory support. Trading at a low valuation, it presents a compelling investment opportunity.

Portfolio Pulse from

November 18, 2024 | 9:45 am

KNBHF

Knorr-Bremse, despite challenges in the trucking sector, remains a solid investment with strong fundamentals. The company's railway segment shows strong growth, supporting a positive long-term investment thesis. The price target has been revised to €95/share.

Portfolio Pulse from

November 18, 2024 | 9:45 am

INTC

The AI Quality Inspection Market is projected to grow significantly from 2024 to 2029, with a CAGR of 20.53%, reaching a market size of $70.747 billion. This growth is driven by the increasing adoption of AI in various industries for quality checks, including semiconductors, pharmaceuticals, textiles, and automotive manufacturing.

Portfolio Pulse from

November 18, 2024 | 9:30 am

HLMAF

Halma PLC has acquired French surgical tools maker Lamidey Noury Medical for €50 million, enhancing its healthcare division. Lamidey Noury specializes in devices for minimally invasive surgeries across various medical fields.

Portfolio Pulse from

November 18, 2024 | 9:30 am

ZTS

Zoetis, a leading animal health company, has demonstrated strong growth since its IPO, with a 17.55% CAGR, outperforming the S&P 500. The company benefits from rising global pet ownership and spending, making its revenues resilient to economic downturns. Zoetis has a strong competitive moat with a diverse product portfolio, significant patent protection, and consistent R&D investment.

Portfolio Pulse from

November 18, 2024 | 9:30 am

NATL

NatWest Group has expanded its partnership with NCR Atleos to modernize its self-service banking channels, enhancing innovation and customer service.

Portfolio Pulse from

November 18, 2024 | 9:15 am

NVDA

Nvidia's stock has slightly declined from its record highs as the market anticipates its third-quarter earnings report. The upcoming earnings and potential positive news from Blackwell chip developments could influence Nvidia's stock performance.

Portfolio Pulse from

November 18, 2024 | 9:15 am